<![CDATA[RSS for Amylin Pharmaceuticals]]> <![CDATA[Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales]]> http://www.foxbusiness.com/news/2013/04/25/bristol-myers-profit-drops-45-on-lower-heart-drug-sales/ http://global.fncstatic.com/static/managed/img/fb2/video/042513_Imus_BMY.jpg <![CDATA[Bristol-Myers Net Drops on Lower Sales of Heart Drugs]]> http://www.foxbusiness.com/news/2013/04/25/bristol-myers-net-drops-on-lower-sales-heart-drugs/ <![CDATA[Eli Lilly Forecasts Stronger 2013]]> http://www.foxbusiness.com/industries/2013/01/04/eli-lilly-expects-2013-earnings-to-rise/ http://global.fncstatic.com/static/managed/img/fb2/news/Mosaic-logo.jpg <![CDATA[S&P Likes a Trio of Biotech ETFs]]> http://www.foxbusiness.com/news/2012/10/24/sp-likes-trio-biotech-etfs/ <![CDATA[Bristol-Myers Posts 3rd-Quarter Loss on Hepatitis C Drug Loss, Sales Down 30%]]> http://www.foxbusiness.com/news/2012/10/24/bristol-myers-posts-3rd-quarter-loss-on-hepatitis-c-drug-loss-sales-down-30/ <![CDATA[Bristol-Myers Sales Slump 30% on Generic Pressure]]> http://www.foxbusiness.com/industries/2012/10/24/bristol-myers-sales-slump-30-on-generic-pressure/ <![CDATA[Eli Lilly Sales Slide 11% on 'Patent Cliff' Struggles]]> http://www.foxbusiness.com/industries/2012/10/24/eli-lilly-sales-slide-11-on-patent-cliff-struggles/ <![CDATA[Eli Lilly Net Up 7.3% on Gain]]> http://www.foxbusiness.com/news/2012/10/24/eli-lilly-net-up-73-on-gain/ <![CDATA[Eli Lilly 3rd-Quarter Net Up 7% on Gain;Gross Margins Decline]]> http://www.foxbusiness.com/news/2012/10/24/eli-lilly-3rd-quarter-net-up-7-on-gaingross-margins-decline/ <![CDATA[Eli Lilly 3rd-Quarter Net Up 7.3% on Gain; Revenue, Margins Decline]]> http://www.foxbusiness.com/news/2012/10/24/eli-lilly-3rd-quarter-net-up-73-on-gain-revenue-margins-decline/ <![CDATA[EARNINGS PREVIEW: U.S. Drug Makers Struggle With Loss of Exclusivity in 3rd Quarter]]> http://www.foxbusiness.com/news/2012/10/09/earnings-preview-us-drug-makers-struggle-with-loss-exclusivity-in-3rd-quarter/ <![CDATA[Icahn Reports Higher Stake in Take-Two, Lower Stake in Commercial Metals]]> http://www.foxbusiness.com/news/2012/08/14/icahn-reports-higher-stake-in-take-two-lower-stake-in-commercial-metals/ <![CDATA[Eli Lilly To Record $1.26 Billion Benefit from Amylin]]> http://www.foxbusiness.com/news/2012/08/09/eli-lilly-to-record-126-billion-benefit-from-amylin/ <![CDATA[Eli Lilly Boosts 2012 Net Profit Forecast]]> http://www.foxbusiness.com/industries/2012/08/09/eli-lilly-boosts-2012-net-profit-forecast/ http://global.fncstatic.com/static/managed/img/U.S./081109_elc.jpg <![CDATA[AstraZeneca: Bristol-Myers Squibb Completes Purchase of Amylin]]> http://www.foxbusiness.com/news/2012/08/09/astrazeneca-bristol-myers-squibb-completes-purchase-amylin/ <![CDATA[Bristol-Myers Exec Arrested for Insider Trading]]> http://www.foxbusiness.com/industries/2012/08/02/bristol-myers-shares-hammered-on-hepatitis-trial-halt-insider-trading-arrest/ http://global.fncstatic.com/static/managed/img/fb2/investing/fdaTrial.jpg <![CDATA[Evercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking Revenue]]> http://www.foxbusiness.com/news/2012/07/26/evercore-2nd-quarter-profit-climbs-1-on-higher-investment-banking-revenue/ <![CDATA[Bristol-Myers Profit Falls 28%]]> http://www.foxbusiness.com/news/2012/07/25/bristol-myers-profit-falls-28/ <![CDATA[Icahn Sounds The Alarm on Forest Labs]]> http://www.foxbusiness.com/news/2012/07/24/icahn-sounds-alarm-on-forest-labs/ <![CDATA[Amylin Pharmaceuticals, Constellation Brands Among Stocks Setting 52-Week Highs Monday]]> http://www.foxbusiness.com/markets/2012/07/02/amylin-pharmaceuticals-constellation-brands-among-stocks-setting-52-week-highs/